ABSTRACT: Hammerhead ribozymes were modi.fied in the 2' -position by flouro-, amino-, deoxy-, O-methyl-and methoxyethoxy-groups to stabilize against degradations. They were tested for their ability to cut specifi.::ally oncogenic N-ras RNA in vitro. Exogenous delivery by lipofection as well as viral vector mediated transfection showed comparable results in reducing N-ras mRNA.
INTRODUCTION: Synthetic oligonucleotides show great promise as therapeutic entities, be it by acting as antisense, ribozyme or triplex constructs. The latter are based on RNA-structures derived from nature which have to be suitably modified in order to be applicable in cells or living organism.
One of the best understood ribozymes, the hammerhead ribozyme studies the design of therapeutic ribozymes is possible now. Important prerequisites which have to be considered in the design are the target delivery, the stability in cells and the efficient catalysis in destroying the target mRNA.
For target delivery we choose lipofection as one method (exogenous application) and viral vector-mediated delivery (endogenous application) as the other alternative. Since unmodified RNA is unstable in sera chemical modification has to be performed for exogenous delivery. Initially we relied on the studies of Eckstein et a1. 4 in choosing sugar modifications as 2'-fluoro and 2'-amino-substituents. Furthermore 2'-deoxy-, 2'-0-methyl and 2'-methoxyethoxy substituents were tested. For all these modifications efficient catalysis was determined. The introduction of phosphothioates at the ends led to a nearly complete stability.
The growth and differentiation of cells depends on a variety of parameters one of which is a complex signal transduction. The proteins coded by the three ras-genes (Ha-ras, N- Thus, we constructed two ribozymes targeted against these regions named MRE763C and MRE764U. GC transversion at position 763 generates a GUC triplet which is targeted by the ribozyme MRE763C (FIG. 3A) . Ribozyme MRE764U is targeted against a second GT transversion at position 764 generating a GUU triplet (FIG. 3B) .
The ribozymes MRE763C and MRE764U are highly specific as they only cleave The modified ribozymes were incubated in cell culture media at 37°C for up to 120 hand assayed for cleavage as described These results were confirmed by the studies with ribozyme MRE764U. A minor decrease in luciferase activity (20%) was seen with the inactive ribozymes iMRE764U and iMRE763C, which can be explained by an antisense effect.
When HeLa cell clone W#2, which expresses wild-type N-ras sequence, was treated with MRE763C a 20% reduction in luciferase was observed. This value is within the range of the luciferase activity obtained from HeLa cells treated with the inactive form of the ribozyme (iMRE763C) and thus is probably due to an antisense effect of ribozyme MRE763C on the wild-type N-ras/luciferase mRNA.
Although the reduction in luciferase activity suggests that the ribozymes MRE764U and MRE763C cleave the fusion mRNA efficiently, a quantitative assessment of RNA molecules cleaved by the ribozymes is not possible by this assay. For that, a semiquantitative RT-PCR reaction was established. Total RNA was isolated from clone C#3
by the guanidine-isothiocyanate method. Great care was taken11 to estimate the degree of N-ras/luciferase mRNA cleavage during the extraction protocol by using an internal diminishes availability of the ribozyme with a concomitant decrease in efficiency.
Modifications usually lead to higher stablility against digestion by nucleases but are often accompanied by a decrease in catalytic efficiency_
The N-ras/luciferase reporter system used in our studies provides a very sensitive assay to detect ribozyme activity, since the expression of the luciferase reporter gene depends Altogether the chemical approach compares well to the gene therapy strateg~' in reducing the target mRNA.
